1
|
Tate DE, Tanprasertsuk J, Jones RB, Maughan H, Chakrabarti A, Khafipour E, Norton SA, Shmalberg J, Honaker RW. A Randomized Controlled Trial to Evaluate the Impact of a Novel Probiotic and Nutraceutical Supplement on Pruritic Dermatitis and the Gut Microbiota in Privately Owned Dogs. Animals (Basel) 2024; 14:453. [PMID: 38338095 PMCID: PMC10854619 DOI: 10.3390/ani14030453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 01/23/2024] [Accepted: 01/27/2024] [Indexed: 02/12/2024] Open
Abstract
Pruritic dermatitis (PD) is a common presentation of canine allergic skin diseases, with diversity in severity and treatment response due to complex etiopathogenesis. Evidence suggests the gut microbiota (GM) may contribute to the development of canine allergies. A 10-week double-blind randomized controlled trial evaluated a novel probiotic and nutraceutical blend (PNB) on clinical signs of skin allergy, health measures, and the GM of privately owned self-reported pruritic dogs. A total of 105 dogs were enrolled, with 62 included in pruritus and health analysis and 50 in microbiome analysis. The PNB supported greater improvement of owner-assessed clinical signs of PD at week 2 than the placebo (PBO). More dogs that received the PNB shifted to normal pruritus (digital PVAS10-N: <2) by week 4, compared to week 7 for the PBO. While a placebo effect was identified, clinical differences were supported by changes in the GM. The PNB enriched three probiotic bacteria and reduced abundances of species associated with negative effects. The PBO group demonstrated increased abundances of pathogenic species and reduced abundances of several beneficial species. This trial supports the potential of the PNB as a supplemental intervention in the treatment of PD; however, further investigation is warranted, with stricter diagnostic criteria, disease biomarkers and direct veterinary examination.
Collapse
Affiliation(s)
- Devon E. Tate
- NomNomNow Inc., Nashville, TN 37207, USA; (D.E.T.); (J.T.); (R.B.J.)
| | | | - Roshonda B. Jones
- NomNomNow Inc., Nashville, TN 37207, USA; (D.E.T.); (J.T.); (R.B.J.)
| | | | | | - Ehsan Khafipour
- Cargill Inc., Wayzata, MN 55391, USA; (A.C.); (E.K.); (S.A.N.)
| | | | - Justin Shmalberg
- Department of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA
| | - Ryan W. Honaker
- NomNomNow Inc., Nashville, TN 37207, USA; (D.E.T.); (J.T.); (R.B.J.)
| |
Collapse
|
2
|
Nishiyama T, Kusakabe M, Imanishi I, Hisano T, Fukamachi T, Taguchi N, Iyori K, Hsiao YH. A randomised, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis. Vet Dermatol 2023; 34:523-531. [PMID: 37485602 DOI: 10.1111/vde.13193] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 05/07/2023] [Accepted: 07/06/2023] [Indexed: 07/25/2023]
Abstract
BACKGROUND Polyunsaturated fatty acids (PUFA) can be beneficial in the management of canine atopic dermatitis (cAD). A commercial product PCSO-524 containing PUFA has demonstrated anti-inflammatory effects in dogs. HYPOTHESIS/OBJECTIVES To evaluate the efficacy of PCSO-524, in combination with oclacitinib in dogs with cAD. ANIMALS Seventeen client-owned dogs with cAD. MATERIALS AND METHODS A randomised, double-blinded, controlled trial. All dogs were treated with oclacitinib (0.4-0.6 mg/kg) twice a day for 14 days, then once a day until Day (D)42. They were randomly divided into two groups: PCSO-524 (n = 9) and sunflower oil (n = 8). Clinical status was assessed by Canine Atopic Dermatitis Extent and Severity Index, 4th iteration (CADESI-04) and pruritus Visual Analog Scale (pVAS) at baseline (D0), D14, D28 and D42. Trans epidermal water loss (TEWL) was measured at the same time points. RESULTS CADESI scores decreased significantly after treatment and there was a significant difference between the PCSO-524 and the control group at D28 (p = 0.04) and D42 (p = 0.03). The PCSO-524 group also demonstrated a significantly decreased pVAS on D28 and D42 (p < 0.001 and p < 0.001) compared to D0, while significant differences were observed in the control group at D14 and D28 (p < 0.01 and p = 0.04) and not at D42 (p = 0.12). The mean TEWL showed a significant decrease at D28 and D42 in the PCSO-524 group, compared to the control group (p = 0.002 and p < 0.001). CONCLUSIONS AND CLINICAL RELEVANCE The combination of PCSO-524 and oclacitinib may help to alleviate the rebound effect that occurs when tapering down the dosage of oclacitinib, as compared to using oclacitinib alone for the management of cAD.
Collapse
Affiliation(s)
| | | | | | | | | | - Norihito Taguchi
- Vet Derm Tokyo, Dermatological and Laboratory Service for Animals, Fujisawa, Japan
| | - Keita Iyori
- Vet Derm Tokyo, Dermatological and Laboratory Service for Animals, Fujisawa, Japan
| | - Yun-Hsia Hsiao
- Vet Derm Tokyo, Dermatological and Laboratory Service for Animals, Fujisawa, Japan
| |
Collapse
|
3
|
Lee MF, Wang NM, Chen YH, Wu CS, Lee MH, Chu YW. An atopic dermatitis-like murine model by skin-brushed cockroach Per a 2 and oral tolerance induction by Lactococcus lactis-derived Per a 2. PLoS One 2023; 18:e0291162. [PMID: 37676892 PMCID: PMC10484430 DOI: 10.1371/journal.pone.0291162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Accepted: 08/23/2023] [Indexed: 09/09/2023] Open
Abstract
Atopic dermatitis (AD) is a complex, chronic inflammatory skin disease. An estimated 57.5% of asthmatic patients and 50.7% of rhinitis patients are allergic to cockroaches in Taiwan. However, the role of cockroaches in the pathogenesis of AD is undetermined. Oral tolerance might be another strategy for protecting against AD and allergic inflammation by regulating T helper 2 (Th2) immune responses. Aim to examine the underlying immunologic mechanism, we developed an AD-like murine model by skin-brushing with cockroach Per a 2. We also investigated whether the systemic inflammation of AD in this murine model could be improved by specific tolerance to Lactococcus lactis-expressing Per a 2, which was administered orally. Repeated painting of Per a 2 without adjuvant to the skin of mice resulted in increased total IgE, Per a 2-specific IgE, and IgG1, but not IgG2a. In addition, epidermal thickening was significantly increased, there were more scratch episodes, and there were increases in total white blood cells (eosinophil, neutrophil, and lymphocyte) and Th2 cytokines (Interleukin (IL)-4, IL-5, IL-9, and IL-13) in a dose-dependent manner. The results revealed that oral administration of L. lactis-Per a 2 ameliorated Per a 2-induced scratch behavior and decreased the production of total IgE, Per a 2-specific IgE, and IgG1. Furthermore, L. lactis-Per a 2 treatment also suppressed inflammatory infiltration, expressions of thymic stromal lymphopoietin (TSLP) and IL-31 in skin lesions, and downregulated splenic IL-4 and IL-13 in Per a 2-induced AD mice. This study provides evidence supporting that repeated brushing of aeroallergens to the skin leads to atopic dermatitis phenotypes and oral allergen-specific immune tolerance can ameliorate AD-like symptoms and systemic inflammation and prevent progression of atopic march.
Collapse
Affiliation(s)
- Mey-Fann Lee
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan
| | - Nancy M. Wang
- Department of Biology, National Changhua University of Education, Changhua, Taiwan
| | - Yi-Hsing Chen
- Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan
| | - Chi-Sheng Wu
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan
| | - Ming-Hao Lee
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan
| | - Yu-Wen Chu
- Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan
- Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
| |
Collapse
|
4
|
Bruet V, Mosca M, Briand A, Bourdeau P, Pin D, Cochet-Faivre N, Cadiergues MC. Clinical Guidelines for the Use of Antipruritic Drugs in the Control of the Most Frequent Pruritic Skin Diseases in Dogs. Vet Sci 2022; 9:vetsci9040149. [PMID: 35448647 PMCID: PMC9030482 DOI: 10.3390/vetsci9040149] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Revised: 03/13/2022] [Accepted: 03/15/2022] [Indexed: 12/10/2022] Open
Abstract
Pruritus is a common clinical sign in many skin disorders and is currently the main complaint in canine dermatology. Pruritic skin diseases can affect the quality of life of dogs and their owners. Several families of antipruritic drugs are available to help control pruritus in dogs. The aim of this review is to help practitioners select the most appropriate symptomatic treatment in the most frequent situations of dermatological pruritus in dogs. The molecules reviewed here are systemic and topical glucocorticoids, antihistamines, ciclosporin, oclacitinib and lokivetmab. A level of evidence (1, 2 or 3) has been established according to a detailed algorithm for each individual study in the literature published between 1990 and March 2021. The guidelines result from evidence grading using the strength of recommendation taxonomy (SoRT) and clinical recommendations using a thorough methodology.
Collapse
Affiliation(s)
- Vincent Bruet
- Veterinary Dermatology Referral Services, 44100 Nantes, France;
| | - Marion Mosca
- Université de Lyon, VetAgro Sup, Interactions Cells Environment, UPSP 2016.A104, 69280 Marcy l’Etoile, France; (M.M.); (D.P.)
| | - Amaury Briand
- Department of Dermatology, Ecole Nationale Vétérinaire d’Alfort, 94700 Maisons-Alfort, France; (A.B.); (N.C.-F.)
| | - Patrick Bourdeau
- Department of Clinical Sciences, ENVN (Oniris) Université de Nantes, 44307 Nantes, France;
| | - Didier Pin
- Université de Lyon, VetAgro Sup, Interactions Cells Environment, UPSP 2016.A104, 69280 Marcy l’Etoile, France; (M.M.); (D.P.)
| | - Noëlle Cochet-Faivre
- Department of Dermatology, Ecole Nationale Vétérinaire d’Alfort, 94700 Maisons-Alfort, France; (A.B.); (N.C.-F.)
- UMR BIPAR, Laboratoire de Santé Animale, 94700 Maisons-Alfort, France
| | - Marie-Christine Cadiergues
- Department of Clinical Sciences, Université de Toulouse, ENVT, 31076 Toulouse, France
- INFINITy, Université de Toulouse, Inserm, CNRS, UPS, 31059 Toulouse, France
- Correspondence: ; Tel.: +33-561-193268
| |
Collapse
|
5
|
Outerbridge CA, Jordan TJ. Current Knowledge on Canine Atopic Dermatitis: Pathogenesis and Treatment. ADVANCES IN SMALL ANIMAL CARE 2021; 2:101-115. [PMID: 35721364 PMCID: PMC9204668 DOI: 10.1016/j.yasa.2021.07.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Affiliation(s)
- Catherine A. Outerbridge
- Department of Medicine and Epidemiology School of Veterinary Medicine, University of California, Davis, Davis, CA 95691, USA
- Corresponding author. Department of Medicine and Epidemiology School of Veterinary Medicine, University of California, Davis, Davis, CA 95691, USA,
| | - Tyler J.M. Jordan
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27606, USA
- Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, 115 Mason Farm Road, Chapel Hill, NC 27599, USA
| |
Collapse
|
6
|
Olivry T, Paps JS, Amalric N. Transient and reversible reduction of stratum corneum filaggrin degradation products after allergen challenge in experimentally mite-sensitised atopic dogs. Vet Dermatol 2021; 33:62-e20. [PMID: 34519121 DOI: 10.1111/vde.13026] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/04/2021] [Indexed: 11/29/2022]
Abstract
BACKGROUND A defective skin barrier occurs in dogs with atopic dermatitis, and there is controversy over whether this defect pre-exists, or is secondary to allergic inflammation. OBJECTIVES To study if an allergen challenge decreases the natural moisturising factor (NMF), which contains the main filaggrin degradation products. ANIMALS Four house dust mite (HDM)-sensitised adult atopic dogs from a research colony. METHODS AND MATERIALS Dogs were challenged epicutaneously with HDMs on the right lateral abdomen while the left thorax served as control. We swabbed the skin surface before, and at days (D)1, D2, D3, D7 and D28 after challenge, on both selected sites; swabs were soaked in detergent and frozen until assayed. The NMF components were measured by liquid chromatography-tandem mass spectrometry (LC/MS-MS). RESULTS The allergen challenge induced moderate skin lesions at the application sites, and also mild erythema at the control areas. The allergen provocation led to significant decreases in the total NMF and its components trans-urocanic acid (t-UCA), pyrrolidone carboxylic acid (PCA) and serine on both sites. Lesion scores abated by D7 and the NMF concentrations had re-increased by D28. Skin lesion scores correlated negatively with the total NMF, t-UCA and PCA concentrations. CONCLUSIONS AND CLINICAL IMPORTANCE In this experimental model, a single epicutaneous allergen challenge led to a transient and reversible decrease in skin surface NMF and its components, and concentrations were negatively correlated with skin lesion scores. These observations suggest that some of the skin barrier anomalies seen in atopic dogs likely develop secondarily to the underlying cutaneous allergic inflammation.
Collapse
Affiliation(s)
- Thierry Olivry
- Department of Clinical Sciences, College of Veterinary Medicine, NC State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA.,Comparative Medicine Institute, NC State University, Raleigh, NC, 27606, USA
| | - Judy S Paps
- Department of Clinical Sciences, College of Veterinary Medicine, NC State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA
| | - Nicolas Amalric
- Synelvia, 516 rue Pierre et Marie Curie, Labège, F-31670, France
| |
Collapse
|
7
|
Léonard C, Taminiau B, Ngo J, Fantini O, Daube G, Fontaine J. Preventive use of a topical anti-inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota. Vet Dermatol 2021; 32:355-e98. [PMID: 34033155 DOI: 10.1111/vde.12977] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/29/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND Otitis externa is associated with a lack of bacterial/fungal diversity in atopic dermatitis. Clinical experience has shown that use of topical corticosteroids in the ear canal (EC) can prevent otitis. No data are available on the impact of this treatment on the EC microbiota. HYPOTHESIS/OBJECTIVES To observe the bacterial/fungal diversity in the EC and the clinical effect of topical corticosteroids administered over a four week period in atopic dogs without active otitis. ANIMALS Ten atopic dogs without active otitis. METHODS AND MATERIALS Mometasone was applied in the right EC, while the left was used as control. A clinical and cytological evaluation of the EC was performed. Swabs of each EC were analysed using next-generation sequencing methods. RESULTS At the beginning of the trial, variations in microbiota and mycobiota were observed between dogs and also within individuals. Statistically, no significant difference was observed in alpha and beta diversity between the treated and the untreated group over time. Clinically, right and left EC diversities were no different at Day (D)28 (P = 0.28). A significant difference was noted between D0 and D28 for the treated ears (P = 0.012) and not for the untreated ears (P = 0.63). No cytological evidence of microbes was found for treated ECs at D28. CONCLUSIONS AND CLINICAL RELEVANCE These data suggest that the use of topical corticosteroids as proactive treatment is unlikely to increase the risk of secondary microbial overgrowth. The positive clinical effect of this proactive treatment seems to be supported through cytological and otoscopic improvement.
Collapse
Affiliation(s)
- Caroline Léonard
- Department for Clinical Sciences B67, Faculty of Veterinary Medicine, Université de Liège, Quartier Vallée 2, B44, Boulevard de Colonster 3, Liège, 4000, Belgium
| | - Bernard Taminiau
- Laboratory of Food Microbiology, Fundamental and applied Research for Animals and Health center (FARAH), Université de Liège, Quartier Vallée 2, B42, Avenue de Cureghem 180, Liège, 4000, Belgium
| | - Jérome Ngo
- Animal Clinic, 425 avenue Brugmann, Brussels, 1180, Belgium
| | - Oscar Fantini
- Vetoquinol SA, 37 rue de la Victoire, Paris, 75009, France
| | - Georges Daube
- Laboratory of Food Microbiology, Fundamental and applied Research for Animals and Health center (FARAH), Université de Liège, Quartier Vallée 2, B42, Avenue de Cureghem 180, Liège, 4000, Belgium
| | - Jacques Fontaine
- Department for Clinical Sciences B67, Faculty of Veterinary Medicine, Université de Liège, Quartier Vallée 2, B44, Boulevard de Colonster 3, Liège, 4000, Belgium
| |
Collapse
|
8
|
Szczepanik M, Wilkołek P, Gołyński M, Sitkowski W, Taszkun I, Toczek W. The influence of treatment with lokivetmab on transepidermal water loss (TEWL) in dogs with spontaneously occurring atopic dermatitis. Vet Dermatol 2019; 30:330-e93. [PMID: 31090122 DOI: 10.1111/vde.12758] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/02/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND Atopic dermatitis (AD) is one of the most common skin diseases in dogs. Monitoring the progress of treatment may include assessment of lesion severity by use of Canine Atopic Dermatitis Extent and Severity Index (CADESI), assessment of pruritus and measurement of biophysical parameters of the skin. HYPOTHESIS This study aimed to assess changes in transepidermal water loss (TEWL) during 12 weeks of treatment with lokivetmab and its correlation with the CADESI-04 and the severity of pruritus. ANIMALS Ten client-owned dogs with canine AD. METHODS AND MATERIALS The animals were administered lokivetmab three times at four week intervals. Pruritus and CADESI-04 were assessed, and TEWL was measured at six body regions, on Day 0 and repeated at weeks 4, 8 and 12. RESULTS There was a significant decrease in the CADESI-04 score, the severity of pruritus and the mean TEWL between baseline and each of the time points. TEWL also decreased in the majority of body sites examined. Significant correlations between the CADESI-04 and mean TEWL (r = 0.519, P = 0.0003), and between pruritus severity and mean TEWL (r = 0.517, P = 0.0003), were found. CONCLUSIONS AND CLINICAL SIGNIFICANCE Overall TEWL decreased during lokivetmab treatment but not at all body sites. If TEWL is used to assess the effectiveness of a treatment, a mean TEWL score should be calculated from several areas of the body.
Collapse
Affiliation(s)
- Marcin Szczepanik
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612, Lublin, Poland
| | - Piotr Wilkołek
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612, Lublin, Poland
| | - Marcin Gołyński
- Subdepartment of Internal Diseases of Farm Animals and Horses, University of Life Sciences in Lublin, Głęboka 30, 20-612, Lublin, Poland
| | - Wiesław Sitkowski
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612, Lublin, Poland
| | - Iwona Taszkun
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612, Lublin, Poland
| | - Wojciech Toczek
- Private veterinary practice ul, Straconki 177, 43-300, Bielsko-Biała, Poland
| |
Collapse
|
9
|
Szczepanik MP, Wilkołek PM, Adamek ŁR, Kalisz G, Gołyński M, Sitkowski W, Taszkun I. Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis. CANADIAN JOURNAL OF VETERINARY RESEARCH = REVUE CANADIENNE DE RECHERCHE VETERINAIRE 2018; 82:306-311. [PMID: 30363310 PMCID: PMC6168015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 10/03/2017] [Accepted: 03/12/2018] [Indexed: 06/08/2023]
Abstract
The aim of this study was to demonstrate whether there is a correlation between transepidermal water loss (TEWL) and the severity of skin lesions in cats with feline atopic dermatitis (AD). The severity of symptoms was determined by using 2 scoring systems for clinically assessing the skin lesions in cats: Scoring Feline Allergic Dermatitis (SCORFAD) and Feline Extent and Severity Index (FeDESI). Such a correlation between TEWL and systems for clinically evaluating symptoms has already been shown in humans and dogs. Measurements were taken in 18 European Shorthair cats: 11 females and 7 males. Scores were calculated using SCORFAD and FeDESI and TEWL was measured in 7 areas of the body. Correlations were calculated between SCORFAD and TEWL and between FeDESI and TEWL for each body region and the average TEWL was also calculated with each system. Positive correlations were found between SCORFAD and TEWL in 3 of the examined areas: thorax (r = 0.44, P = 0.02); axilla (r = 0.39, P = 0.04); and forelimb (r = 0.55, P = 0.02). A correlation was also found between the average TEWL and SCORFAD (r = 0.41, P = 0.03). In the case of FeDESI, a correlation was found in the forelimb (r = 0.53, P = 0.02), but no correlation was found between FeDESI and the average TEWL. The results obtained showed that TEWL can be used as an additional tool in clinically assessing atopic dermatitis in cats, although it seems to be less useful in cats than in humans.
Collapse
Affiliation(s)
- Marcin P Szczepanik
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| | - Piotr M Wilkołek
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| | - Łukasz R Adamek
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| | - Grzegorz Kalisz
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| | - Marcin Gołyński
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| | - Wiesław Sitkowski
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| | - Iwona Taszkun
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology (Szczepanik, Wilkołek, Adamek, Kalisz, Sitkowski, Taszkun) and Subdepartment of Internal Diseases of Farm Animals and Horses (Gołyński), Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Głęboka 30, 20-612 Lublin, Poland
| |
Collapse
|
10
|
Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, Prélaud P. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet Res 2015; 11:210. [PMID: 26276051 PMCID: PMC4537558 DOI: 10.1186/s12917-015-0514-6] [Citation(s) in RCA: 148] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2015] [Accepted: 07/30/2015] [Indexed: 12/11/2022] Open
Abstract
Background In 2010, the International Task Force on Canine Atopic Dermatitis (now International Committee on Allergic Diseases of Animals, ICADA) published the first consensus guidelines for the treatment of atopic dermatitis (AD) in dogs. This is the first 5-year minor update of this document. Results The treatment of acute flares of AD should involve the search for, and then elimination of, the cause of the flares, bathing with mild shampoos, and controlling pruritus and skin lesions with interventions that include topical and/or oral glucocorticoids or oclacitinib. For chronic canine AD, the first steps in management are the identification and avoidance of flare factors, as well as ensuring that there is adequate skin and coat hygiene and care; this might include more frequent bathing and possibly increasing essential fatty acid intake. The medications currently most effective in reducing chronic pruritus and skin lesions are topical and oral glucocorticoids, oral ciclosporin, oral oclacitinib, and, where available, injectable recombinant interferons. Allergen-specific immunotherapy and proactive intermittent topical glucocorticoid applications are the only interventions likely to prevent or delay the recurrence of flares of AD. Conclusions This first 5-year minor update of the international consensus guidelines for treatment of AD in dogs further establishes that the treatment of this disease is multifaceted, and that interventions should be combined for a proven (or likely) optimal benefit. Importantly, treatment plans are likely to vary between dogs and, for the same dog, between times when the disease is at different stages. Electronic supplementary material The online version of this article (doi:10.1186/s12917-015-0514-6) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Thierry Olivry
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, 27606, NC, USA.
| | - Douglas J DeBoer
- Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, 2015 Linden Drive, Madison, 53706, WI, USA
| | - Claude Favrot
- Clinic for Small Animal Internal Medicine, Dermatology Department, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 260, 8057, Zürich, Switzerland
| | - Hilary A Jackson
- Dermatology Referral Services LTD, 528 Paisley Road West, Glasgow, Scotland, G51 1RN, UK
| | - Ralf S Mueller
- Medizinische Kleintierklinik, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University, Veterinärstrasse 13, 80539, Munich, Germany
| | - Tim Nuttall
- Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Campus, Roslin, Scotland, EH25 9RG, UK
| | - Pascal Prélaud
- Clinique Advetia, 5 rue Dubrunfaut, Paris, 75012, France
| | | |
Collapse
|
11
|
Zając M, Szczepanik MP, Wilkołek PM, Adamek ŁR, Pomorski ZJH, Sitkowski W, Gołyński MG. Assessment of the relationship between transepidermal water loss (TEWL) and severity of clinical signs (CADESI-03) in atopic dogs. Vet Dermatol 2014; 25:503-6, e83. [DOI: 10.1111/vde.12150] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/27/2014] [Indexed: 01/29/2023]
Affiliation(s)
- Marcin Zając
- Private Veterinary Practice; Szpitalna 9a Czeladź Śląskie 41-250 Poland
| | - Marcin P. Szczepanik
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology; University of Life Sciences in Lublin; Głęboka 30 Lublin 20-612 Poland
| | - Piotr M. Wilkołek
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology; University of Life Sciences in Lublin; Głęboka 30 Lublin 20-612 Poland
| | - Łukasz R. Adamek
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology; University of Life Sciences in Lublin; Głęboka 30 Lublin 20-612 Poland
| | - Zbigniew J. H. Pomorski
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology; University of Life Sciences in Lublin; Głęboka 30 Lublin 20-612 Poland
| | - Wiesław Sitkowski
- Subdepartment of Clinical Diagnostics and Veterinary Dermatology; University of Life Sciences in Lublin; Głęboka 30 Lublin 20-612 Poland
| | - Marcin G. Gołyński
- Subdepartment of Internal Diseases of Farm Animals and Horses; Faculty of Veterinary Medicine; University of Life Sciences in Lublin; Głęboka 30 Lublin 20-612 Poland
| |
Collapse
|